Lung cancer in never smokers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease based on rapidly gained knowledge from genomic changes to treatment responses. The focus of this article is on current knowledge and challenges with regard to LCINS expanded from recent reviews highlighting five areas: (1) distribution of LCINS by temporal trends, geographic regions, and populations; (2) three well-recognized environmental risk factors; (3) other plausible environmental risk factors; (4) prior chronic lung diseases and infectious diseases as risk factors; and (5) lifestyles as risk or protective factors. This article will also bring attention to recently published literature in two pioneering areas: (1) histological characteristics, clinical features with emerging new effective therapies, and social and psychological stigma; and (2) searching for susceptibility genes using integrated genomic approaches.

Original languageEnglish (US)
Pages (from-to)10-21
Number of pages12
JournalSeminars in Respiratory and Critical Care Medicine
Volume32
Issue number1
DOIs
StatePublished - 2011

Fingerprint

Lung Neoplasms
Social Stigma
Lung Diseases
Communicable Diseases
Life Style
Chronic Disease
Psychology
Therapeutics
Population
Genes

Keywords

  • environmental risk factors
  • genetic predisposition
  • Lung cancer
  • molecular target therapy
  • never smokers

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Lung cancer in never smokers. / Yang, Ping.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 32, No. 1, 2011, p. 10-21.

Research output: Contribution to journalArticle

@article{ec60aa0a41dc427ba8e894ccabda4b7a,
title = "Lung cancer in never smokers",
abstract = "Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease based on rapidly gained knowledge from genomic changes to treatment responses. The focus of this article is on current knowledge and challenges with regard to LCINS expanded from recent reviews highlighting five areas: (1) distribution of LCINS by temporal trends, geographic regions, and populations; (2) three well-recognized environmental risk factors; (3) other plausible environmental risk factors; (4) prior chronic lung diseases and infectious diseases as risk factors; and (5) lifestyles as risk or protective factors. This article will also bring attention to recently published literature in two pioneering areas: (1) histological characteristics, clinical features with emerging new effective therapies, and social and psychological stigma; and (2) searching for susceptibility genes using integrated genomic approaches.",
keywords = "environmental risk factors, genetic predisposition, Lung cancer, molecular target therapy, never smokers",
author = "Ping Yang",
year = "2011",
doi = "10.1055/s-0031-1272865",
language = "English (US)",
volume = "32",
pages = "10--21",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Lung cancer in never smokers

AU - Yang, Ping

PY - 2011

Y1 - 2011

N2 - Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease based on rapidly gained knowledge from genomic changes to treatment responses. The focus of this article is on current knowledge and challenges with regard to LCINS expanded from recent reviews highlighting five areas: (1) distribution of LCINS by temporal trends, geographic regions, and populations; (2) three well-recognized environmental risk factors; (3) other plausible environmental risk factors; (4) prior chronic lung diseases and infectious diseases as risk factors; and (5) lifestyles as risk or protective factors. This article will also bring attention to recently published literature in two pioneering areas: (1) histological characteristics, clinical features with emerging new effective therapies, and social and psychological stigma; and (2) searching for susceptibility genes using integrated genomic approaches.

AB - Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease based on rapidly gained knowledge from genomic changes to treatment responses. The focus of this article is on current knowledge and challenges with regard to LCINS expanded from recent reviews highlighting five areas: (1) distribution of LCINS by temporal trends, geographic regions, and populations; (2) three well-recognized environmental risk factors; (3) other plausible environmental risk factors; (4) prior chronic lung diseases and infectious diseases as risk factors; and (5) lifestyles as risk or protective factors. This article will also bring attention to recently published literature in two pioneering areas: (1) histological characteristics, clinical features with emerging new effective therapies, and social and psychological stigma; and (2) searching for susceptibility genes using integrated genomic approaches.

KW - environmental risk factors

KW - genetic predisposition

KW - Lung cancer

KW - molecular target therapy

KW - never smokers

UR - http://www.scopus.com/inward/record.url?scp=79954570724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954570724&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1272865

DO - 10.1055/s-0031-1272865

M3 - Article

VL - 32

SP - 10

EP - 21

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 1

ER -